California State Teachers Retirement System (CalSTRS)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,319
Closed -$3.83K 3093
2025
Q1
$3.83K Sell
8,319
-186,896
-96% -$118K ﹤0.01% 2954
2024
Q4
$144K Buy
195,215
+44,915
+30% +$54.1K ﹤0.01% 2367
2024
Q3
$236K Buy
150,300
+141,981
+1,707% +$253K ﹤0.01% 2356
2024
Q2
$14K Sell
8,319
-997
-11% -$1.79K ﹤0.01% 2754
2024
Q1
$22.4K Sell
9,316
-5,933
-39% -$12.7K ﹤0.01% 2671
2023
Q4
$23.3K Sell
15,249
-102,634
-87% -$122K ﹤0.01% 2868
2023
Q3
$128K Sell
117,883
-6,683
-5% -$11.7K ﹤0.01% 2555
2023
Q2
$285K Buy
124,566
+27,287
+28% +$72.4K ﹤0.01% 2484
2023
Q1
$236K Sell
97,279
-1,960
-2% -$4.49K ﹤0.01% 2551
2022
Q4
$190K Buy
99,239
+3,179
+3% +$6.76K ﹤0.01% 2631
2022
Q3
$231K Buy
96,060
+14,835
+18% +$41.1K ﹤0.01% 2597
2022
Q2
$151K Buy
81,225
+2,499
+3% +$4.77K ﹤0.01% 2751
2022
Q1
$165K Sell
78,726
-7,162
-8% -$19.9K ﹤0.01% 2706
2021
Q4
$338K Buy
85,888
+2,000
+2% +$9.71K ﹤0.01% 2638
2021
Q3
$404K Sell
83,888
-9,946
-11% -$40.8K ﹤0.01% 2523
2021
Q2
$431K Buy
93,834
+18,824
+25% +$90.7K ﹤0.01% 2729
2021
Q1
$440K Buy
75,010
+10,371
+16% +$71.8K ﹤0.01% 2578
2020
Q4
$221K Hold
64,639
﹤0.01% 2798
2020
Q3
$93K Hold
64,639
﹤0.01% 2977
2020
Q2
$129K Hold
64,639
﹤0.01% 2897
2020
Q1
$126K Buy
64,639
+739
+1% +$2.2K ﹤0.01% 2736
2019
Q4
$265K Hold
63,900
﹤0.01% 2677
2019
Q3
$192K Hold
63,900
﹤0.01% 2799
2019
Q2
$402K Sell
63,900
-3,734
-6% -$22.4K ﹤0.01% 2485
2019
Q1
$376K Hold
67,634
﹤0.01% 2456
2018
Q4
$449K Buy
67,634
+1,064
+2% +$8.62K ﹤0.01% 2354
2018
Q3
$710K Buy
66,570
+437
+0.7% +$5.01K ﹤0.01% 2242
2018
Q2
$794K Buy
66,133
+505
+0.8% +$5.17K ﹤0.01% 2196
2018
Q1
$562K Sell
65,628
-2,301
-3% -$21.3K ﹤0.01% 2303
2017
Q4
$671K Sell
67,929
-1,173
-2% -$12.2K ﹤0.01% 2233
2017
Q3
$849K Sell
69,102
-7,233
-9% -$107K ﹤0.01% 2098
2017
Q2
$1.26M Sell
76,335
-6,892
-8% -$107K ﹤0.01% 1908
2017
Q1
$1.19M Sell
83,227
-3,900
-4% -$57.9K ﹤0.01% 1973
2016
Q4
$1.21M Sell
87,127
-2,300
-3% -$36.9K ﹤0.01% 1993
2016
Q3
$1.62M Buy
89,427
+800
+0.9% +$12.9K ﹤0.01% 1782
2016
Q2
$1.27M Buy
88,627
+602
+0.7% +$8.16K ﹤0.01% 1900
2016
Q1
$1.05M Buy
88,025
+11,078
+14% +$116K ﹤0.01% 1991
2015
Q4
$1.02M Buy
76,947
+1,372
+2% +$16.9K ﹤0.01% 1983
2015
Q3
$812K Sell
75,575
-300
-0.4% -$3.28K ﹤0.01% 2109
2015
Q2
$611K Buy
75,875
+10,790
+17% +$79.2K ﹤0.01% 2431
2015
Q1
$430K Sell
65,085
-1,543
-2% -$10.5K ﹤0.01% 2546
2014
Q4
$424K Buy
66,628
+6,358
+11% +$51.3K ﹤0.01% 2579
2014
Q3
$595K Buy
60,270
+671
+1% +$7.17K ﹤0.01% 2337
2014
Q2
$672K Buy
59,599
+828
+1% +$8.89K ﹤0.01% 2318
2014
Q1
$712K Hold
58,771
﹤0.01% 2202
2013
Q4
$741K Buy
58,771
+343
+0.6% +$5.46K ﹤0.01% 2176
2013
Q3
$969K Buy
58,428
+1,839
+3% +$30.8K ﹤0.01% 1953
2013
Q2
$860K Buy
+56,589
New +$860K ﹤0.01% 1957

Other funds holding LXRX

California State Teachers Retirement System (CalSTRS)'s LXRX Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2025, closing a stake of 8,319 shares — an estimated $3.83K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in LXRX in Q2 2013 and held it in 48 quarters. The position peaked at $1.62M in Q3 2016. 123 funds tracked by Wall St. Rank hold LXRX as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Lexicon Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 8,319 Lexicon Pharmaceuticals shares in Q2 2025, an estimated $3.83K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 48 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Lexicon Pharmaceuticals position peaked at $1.62M in Q3 2016.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.